EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functional insights into Streptomyces isolates containing both clavulanic acid-like and carbapenem biosynthetic gene clusters

Kapil Tahlan iD, Arshad Ali Shaikh, Jingyu Liu, Kajal Gupta, Nader AbuSara, Santosh Kumar Srivastava, Adau Deng, Ayla Rouah, Madelyn Joan Swackhamer

mSphere · 2025

DOI: 10.1128/msphere.00188-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSphere, 2025. Verfasst von Kapil Tahlan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada. Hauptthemen laut MEDLINE: Streptomyces, Multigene Family, Clavulanic Acid, Carbapenems. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

β-Lactam antibiotics and β-lactamase inhibitor combinations are essential for combating antimicrobial resistance, with many β-lactams, including clavulanic acid (CA), themselves being products of specialized metabolic pathways in bacteria. CA is a potent β-lactamase inhibitor, and in known producers such as Streptomyces clavuligerus , it is co-produced with the β-lactam antibiotic cephamycin C, and their biosynthetic gene clusters (BGCs) are always located adjacent on the chromosome. However, CA-like BGCs have also been identified in other bacteria, often without an accompanying cephamycin C BGC. Similarly, carbapenem BGCs (a subclass of β-lactams), such as those responsible for producing MM 4550, a member of the olivanic acid complex with both antibiotic and β-lactamase inhibitory properties, are also found in Streptomyces species. This study investigated antimicrobial and β-lactamase inhibitory activity production in Streptomyces pratensis and 10 environmental Streptomyces isolates (JAC strains) containing CA-like and MM 4550-like BGCs but lacking cephamycin C BGCs. While the examined isolates do not produce CA, they synthesize predicted monocyclic β-lactam precursors of CA, which potentially represent a previously unrecognized, primordial form of β-lactamase inhibitor. Several JAC isolates also exhibited both β-lactamase inhibitory and β-lactam antibiotic activities, indicating that the carbapenem BGC is active in these strains. Gene disruption analysis confirmed that MM 4550-like carbapenem BGCs contribute to both antimicrobial and β-lactamase inhibitory activities, whereas CA-like clavam BGCs only contribute to β-lactamase inhibition. The findings also suggest that both β-lactam BGC types co-occur in nature more frequently than previously recognized, possibly with functional significance and potential applications in the discovery of novel antibiotic-inhibitor combinations. IMPORTANCE The global rise of antimicrobial resistance calls for innovative strategies to preserve the efficacy of existing antibiotics and identify new therapeutic agents. This study explores naturally occurring β-lactamase inhibitors and antibiotics beyond well-characterized systems. Investigation of clavulanic acid (CA)-like and MM 4550-like biosynthetic gene clusters (BGCs) in Streptomyces pratensis and related environmental isolates revealed a broader occurrence of monocyclic β-lactam precursors and dual-function carbapenems in nature. These findings offer new insights into β-lactam co-production and further indicate that unlinked β-lactam BGCs may have functional significance. The study also highlights the importance of exploring silent counterparts of known BGCs as potential sources of bioactive metabolites, enhancing our understanding of β-lactam BGC diversity and evolution. Notably, it identifies β-lactamase inhibitor and antibiotic-producing strains, opening new avenues for discovering antibiotic-inhibitor combinations of relevance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StreptomycesMultigene FamilyClavulanic AcidCarbapenemsBiosynthetic PathwaysAnti-Bacterial Agentsbeta-Lactamase Inhibitorsbeta-LactamasesMicrobial Sensitivity TestsCephamycins

Stichwörter der Autor:innen

Streptomycesbiosynthetic gene clustercarbapenemclavulanic acidβ-lactamβ-lactamase inhibition

Substanzen

Clavulanic AcidCarbapenemsAnti-Bacterial Agentsbeta-Lactamase Inhibitorsbeta-LactamasesCephamycins

Autor:innen und Institutionen

  • Department of Biology, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.

ORCID-Profile: Kapil Tahlan

Förderung

  • Natural Sciences and Engineering Research Council of Canada

Zitieren

APA

Tahlan, K., Shaikh, A. A., Liu, J., Gupta, K., AbuSara, N., Srivastava, S. K., Deng, A., Rouah, A., & Swackhamer, M. J. (2025). Functional insights into Streptomyces isolates containing both clavulanic acid-like and carbapenem biosynthetic gene clusters. mSphere. https://doi.org/10.1128/msphere.00188-25

Vancouver

Tahlan K, Shaikh AA, Liu J, Gupta K, AbuSara N, Srivastava SK, et al. Functional insights into Streptomyces isolates containing both clavulanic acid-like and carbapenem biosynthetic gene clusters. mSphere. 2025. doi:10.1128/msphere.00188-25

BibTeX
@article{Tahlan2025,
  author = {Tahlan, Kapil and Shaikh, Arshad Ali and Liu, Jingyu and Gupta, Kajal and AbuSara, Nader and Srivastava, Santosh Kumar and Deng, Adau and Rouah, Ayla and Swackhamer, Madelyn Joan},
  title = {Functional insights into Streptomyces isolates containing both clavulanic acid-like and carbapenem biosynthetic gene clusters},
  journal = {mSphere},
  year = {2025},
  doi = {10.1128/msphere.00188-25}
}
Kostenlos starten →